Ronald Booth, University of Ottawa

Research

Read how they describe their research on their University of Ottawa profile.

Latest papers

Clinical and serological predictors of post COVID-19 condition-findings from a Canadian prospective cohort study.
Frontiers in public health · 2024
Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination.
BMJ open · 2023
Cohort profile: Stop the Spread Ottawa (SSO)-a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination.
BMJ open · 2022

All 5 publications

Latest funding

COVID-19 Variant Supplement - Analysis of Antibody Neutralization Efficiency and Cellular Immunity in SARS-CoV-2-Positive Individuals Identified in At-Risk Individuals
CIHR · 2021 · Co-investigator
$50,000
COVID-19 Variant Network - Analysis of Antibody Neutralization Efficiency and Cellular Immunity in SARS-CoV-2-Positive Individuals Identified in At-Risk Individuals
CIHR · 2021 · Co-investigator
$100,000
Analysis of Antibody Neutralization Efficiency and Cellular Immunity in SARS-CoV-2-Positive Individuals Identified in At-Risk Individuals
CIHR · 2020 · Co-investigator
$2,112,500

All 3 grants and awards

5 publications.

01

Clinical and serological predictors of post COVID-19 condition-findings from a Canadian prospective cohort study.

Collins E, Galipeau Y, Arnold C, Bhéreur A, Booth R, Buchan AC, Cooper C, Crawley AM, McCluskie PS, McGuinty M, Pelchat M, Rocheleau L, Saginur R, Gravel C, Hawken S, Langlois MA, Little J

Frontiers in public health2024

DOI: 10.3389/fpubh.2024.1276391 PMID: 38784593

02

Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination.

Keeshan A, Galipeau Y, Heiskanen A, Collins E, McCluskie PS, Arnold C, Saginur R, Booth R, Little J, McGuinty M, Buchan CA, Crawley A, Langlois MA, Cooper C

BMJ open2023

DOI: 10.1136/bmjopen-2023-077714 PMID: 37907304

03

Cohort profile: Stop the Spread Ottawa (SSO)-a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination.

Collins E, Galipeau Y, Arnold C, Bosveld C, Heiskanen A, Keeshan A, Nakka K, Shir-Mohammadi K, St-Denis-Bissonnette F, Tamblyn L, Vranjkovic A, Wood LC, Booth R, Buchan CA, Crawley AM, Little J, McGuinty M, Saginur R, Langlois MA, Cooper CL

BMJ open2022

DOI: 10.1136/bmjopen-2022-062187 PMID: 36691221

04

Serum neurofilament light in MS: The first true blood-based biomarker?

Thebault S, Bose G, Booth R, Freedman MS

Multiple sclerosis (Houndmills, Basingstoke, England)2022

DOI: 10.1177/1352458521993066 PMID: 33565908

05

Are Anti-β2 Glycoprotein 1 Antibodies Associated with Placenta-Mediated Pregnancy Complications? A Nested Case-Control Study.

Skeith L, Abou-Nassar KE, Walker M, Ramsay T, Booth R, Wen SW, Smith GN, Rodger MA

American journal of perinatology2018

DOI: 10.1055/s-0038-1641168 PMID: 29635655

COVID-19 Variant Supplement - Analysis of Antibody Neutralization Efficiency and Cellular Immunity in SARS-CoV-2-Positive Individuals Identified in At-Risk Individuals

Co-investigatorCIHR2021Operating Grant: SARS-CoV-2 variants supplement stream 1

Principal investigators: Langlois, Marc-Andre

Keywords: Antibodies; Cellular Immunity; Covid-19; Molecular Virology; Sars-Cov-2; Serology; Viral Load Testing; Virus Neutralization

$50,000

COVID-19 Variant Network - Analysis of Antibody Neutralization Efficiency and Cellular Immunity in SARS-CoV-2-Positive Individuals Identified in At-Risk Individuals

Co-investigatorCIHR2021Operating Grant: SARS-CoV-2 variants supplement stream 2

Principal investigators: Langlois, Marc-Andre

Keywords: Antibodies; Cellular Immunity; Covid-19; Molecular Virology; Sars-Cov-2; Serology; Viral Load Testing; Virus Neutralization

$100,000

Analysis of Antibody Neutralization Efficiency and Cellular Immunity in SARS-CoV-2-Positive Individuals Identified in At-Risk Individuals

Co-investigatorCIHR2020Operating Grant: COVID-19 Rapid Research Funding Opportunity - Diagnostics

Principal investigators: Langlois, Marc-Andre

Keywords: Antibodies; Cellular Immunity; Covid-19; Molecular Virology; Sars-Cov-2; Serology; Viral Load Testing; Virus Neutralization

$2,112,500

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Frequent collaborators

School of Epidemiology and Public Health
Department of Medicine
Biochemistry, Microbiology and Immunology
Pathology and Laboratory Medicine
Medicine
Obstetrics and Gynecology
Other

Co-authors at University of Ottawa, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Julian Little

School of Epidemiology and Public Health

3 shared papers, latest 2024

Raphael Saginur

Department of Medicine

3 shared papers, latest 2024

Michaeline McGuinty

Faculty

3 shared papers, latest 2024

Curtis Cooper

Department of Medicine

2 shared papers, latest 2024

Steven Hawken

School of Epidemiology and Public Health

1 shared papers, latest 2024

Leslie Skeith

Medicine

1 shared papers, latest 2018

Marc-André Langlois

Biochemistry, Microbiology and Immunology

1 shared papers, latest 2023

Martin Pelchat

Biochemistry, Microbiology and Immunology

1 shared papers, latest 2024

Mark Walker

Obstetrics and Gynecology

1 shared papers, latest 2018

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student Dear Professor Booth, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Clinical and serological predictors of post COVID-19 condition-findings from a Canadian prospective cohort study." (2024), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Ronald Booth

Research

Latest papers

Latest funding

Clinical and serological predictors of post COVID-19 condition-findings from a Canadian prospective cohort study.

Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination.

Cohort profile: Stop the Spread Ottawa (SSO)-a community-based prospective cohort study on antibody responses, antibody neutralisation efficiency and cellular immunity to SARS-CoV-2 infection and vaccination.

Serum neurofilament light in MS: The first true blood-based biomarker?

Are Anti-&#x3b2;2 Glycoprotein 1 Antibodies Associated with Placenta-Mediated Pregnancy Complications? A Nested Case-Control Study.

COVID-19 Variant Supplement - Analysis of Antibody Neutralization Efficiency and Cellular Immunity in SARS-CoV-2-Positive Individuals Identified in At-Risk Individuals

COVID-19 Variant Network - Analysis of Antibody Neutralization Efficiency and Cellular Immunity in SARS-CoV-2-Positive Individuals Identified in At-Risk Individuals

Analysis of Antibody Neutralization Efficiency and Cellular Immunity in SARS-CoV-2-Positive Individuals Identified in At-Risk Individuals

Frequent collaborators

Julian Little

Raphael Saginur

Michaeline McGuinty

Curtis Cooper

Steven Hawken

Leslie Skeith

Marc-André Langlois

Martin Pelchat

Mark Walker

Are Anti-β2 Glycoprotein 1 Antibodies Associated with Placenta-Mediated Pregnancy Complications? A Nested Case-Control Study.